Patrick J. Nolan

Array ( [id] => 773169 [patent_doc_number] => 07001734 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Process for identifying para cation channel modulators' [patent_app_type] => utility [patent_app_number] => 08/554424 [patent_app_country] => US [patent_app_date] => 1995-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10048 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001734.pdf [firstpage_image] =>[orig_patent_app_number] => 08554424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1165591 [patent_doc_number] => 06759517 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Allergenic proteins of natural rubber latex, their production and use in assays' [patent_app_type] => B1 [patent_app_number] => 08/529152 [patent_app_country] => US [patent_app_date] => 1995-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 12028 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759517.pdf [firstpage_image] =>[orig_patent_app_number] => 08529152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459139 [patent_doc_number] => 06391651 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Materials and methods for detection of insulin dependent diabetes' [patent_app_type] => B1 [patent_app_number] => 08/514213 [patent_app_country] => US [patent_app_date] => 1995-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10113 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391651.pdf [firstpage_image] =>[orig_patent_app_number] => 08514213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996239 [patent_doc_number] => 05919912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Mammalian IAP antibodies and diagnostic kits' [patent_app_type] => 1 [patent_app_number] => 8/511485 [patent_app_country] => US [patent_app_date] => 1995-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 11 [patent_no_of_words] => 19301 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919912.pdf [firstpage_image] =>[orig_patent_app_number] => 511485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659546 [patent_doc_number] => 05659018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Mocarhagin, a cobra venom protease, and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/520977 [patent_app_country] => US [patent_app_date] => 1995-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7635 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/659/05659018.pdf [firstpage_image] =>[orig_patent_app_number] => 520977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842553 [patent_doc_number] => 20030147900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THERE OF' [patent_app_type] => new [patent_app_number] => 08/765837 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8185 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147900.pdf [firstpage_image] =>[orig_patent_app_number] => 08765837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689260 [patent_doc_number] => 05679339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Method of using IL-11 for treating spondyloarthropies' [patent_app_type] => 1 [patent_app_number] => 8/495724 [patent_app_country] => US [patent_app_date] => 1995-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6178 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679339.pdf [firstpage_image] =>[orig_patent_app_number] => 495724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862148 [patent_doc_number] => 05837247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Chemotactic agents for t-cells' [patent_app_type] => 1 [patent_app_number] => 8/491204 [patent_app_country] => US [patent_app_date] => 1995-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9459 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837247.pdf [firstpage_image] =>[orig_patent_app_number] => 491204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326318 [patent_doc_number] => 06599706 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Recombinant PR-3 and assays employing the same' [patent_app_type] => B1 [patent_app_number] => 08/487453 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 29794 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599706.pdf [firstpage_image] =>[orig_patent_app_number] => 08487453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278896 [patent_doc_number] => 06641813 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Methods and reagents for diagnosis of autoantibodies' [patent_app_type] => B1 [patent_app_number] => 08/475955 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641813.pdf [firstpage_image] =>[orig_patent_app_number] => 08475955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770238 [patent_doc_number] => 05807675 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Fluorescent oxygen channeling immunoassays' [patent_app_type] => 1 [patent_app_number] => 8/479743 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23778 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807675.pdf [firstpage_image] =>[orig_patent_app_number] => 479743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101169 [patent_doc_number] => 06066621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Synthetic peptides for the treatment of myasthenia gravis' [patent_app_type] => 1 [patent_app_number] => 8/475577 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 11536 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066621.pdf [firstpage_image] =>[orig_patent_app_number] => 475577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866133 [patent_doc_number] => 05837497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'DNAs encoding mammalian ZPC and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/484993 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24975 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837497.pdf [firstpage_image] =>[orig_patent_app_number] => 484993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043338 [patent_doc_number] => 05874409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies' [patent_app_type] => 1 [patent_app_number] => 8/482651 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 19202 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874409.pdf [firstpage_image] =>[orig_patent_app_number] => 482651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937595 [patent_doc_number] => 05976545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'ZPC polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/484158 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 53483 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976545.pdf [firstpage_image] =>[orig_patent_app_number] => 484158 [rel_patent_id] =>[rel_patent_doc_number] =>)